Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Sorrento Announces Drilling Contract & Receives Permit to Drill Bottom Brook Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Biostar Pharmaceuticals Inc (EM) BSPM

Healthcare Biotechnology Drug Manufacturers - Specialty & Generic
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People’s Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The... see more

Current News (EXPM:BSPM)

Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from Nasdaq

GlobeNewswire August 23, 2018

Biostar Pharmaceuticals Received Nasdaq Delisting Notification

ACCESS Newswire July 25, 2018

Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice

ACCESS Newswire May 30, 2018

Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice

PR Newswire April 23, 2018

15 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  March 20, 2018

Biostar Pharmaceuticals, Inc. Announces Plans to Launch a New eCommerce Sales Platform

PR Newswire February 21, 2018

Shaanxi Aoxing Pharmaceutical Co., Ltd. Renewed its GMP Certification

PR Newswire February 7, 2018

Biostar Regains Compliance with NASDAQ Continued Listing Requirement

PR Newswire December 4, 2017

Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Nine Months Ended September 30, 2017

PR Newswire November 20, 2017
View More News ››

Opinion & Analysis (EXPM:BSPM)

Micro cap pharma (BSPM) receives Chinese herbal patent

Peter Szafranski October 7, 2009
View More Opinion ››

Bullboard Posts (EXPM:BSPM)

RE:BSPM

Been here for about 6 months will definitely be holding on for some time. Not even close to where this one is headed. I see much upward...
profitonly - March 6, 2014

BSPM

profitonly - March 6, 2014

Solid gain from BSPM today

Biostar up big right now. About time I've been waiting for this one for a while. Wish it were up more though Biostar Pharma
dollarbags23 - November 15, 2013
View more Bullboard ››

G Mining Ventures Corp.

G Mining Ventures Corp.

G Mining Ventures Corp., a mining company, engages in the acquisition, exploration, and development of precious metal ...
View More »

Podcasts